PT  - JOURNAL ARTICLE
AU  - Samson Omongot
AU  - Winters Muttamba
AU  - Irene Najjingo
AU  - Joseph Baruch Baluku
AU  - Sabrina Kitaka
AU  - Stavia Turyahabwe
AU  - Bruce Kirenga
TI  - Strategies to resolve the gap in Adolescent Tuberculosis care at four health facilities in Uganda: The TEEN TB pilot project
AID  - 10.1101/2023.05.25.23290553
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.25.23290553
4099  - http://medrxiv.org/content/early/2023/06/04/2023.05.25.23290553.short
4100  - http://medrxiv.org/content/early/2023/06/04/2023.05.25.23290553.full
AB  - Introduction In 2021, an estimated 10.6 million people fell ill with tuberculosis (TB) globally, 1.2 million of these were children. About 40% of them aged between 5 and 14 years with TB are missed annually. In Uganda, 44% of adolescents with chronic cough of ≥2 weeks do not seek care from health facilities. Therefore, strategies to promote health care-seeking behaviour among adolescents are urgently needed. We piloted a project (TEEN TB project) aimed at improving uptake of tuberculosis (TB) care services among adolescents at Ugandan health facilities.Methodology We developed an adolescent TB awareness and screening package using the human centred design. This technique puts real people at the centre of the development process. The package consisted of 3 interventions (TB screening cards, adolescent-TB awareness poster messages and a local TB awareness song) deployed in the project health facilities and their surrounding communities. Data on socio-demographic and clinical characteristics of adolescents were collected for the period between October 2021 and March 2022 at 4 project health facilities (Kawolo, Iganga, Gombe and Kiwoko). We collected before and after intervention data from facility level records to determine the effect of the package.Results A total of 394 adolescents were included and the majority (76%) were still in school. Overall, the intervention improved adolescent TB care in the four project health facilities. The average number of adolescents screened increased by 94% from 159 to 309, with an incidence rate ratio (IRR) of 1.9 (95% CI: 1.9-2.0, p <0.001), there was a 2-fold increase among those presumed to have TB; from 13 to 29, IRR of 2.2 (95% CI: 1.9-2.5, p <0.001) and those tested with GeneX-pert and microscopy increased more than 3 times from 8 to 28, IRR of 3.3 (95% CI: 2.8-3.8, p <0.001). There was a minimal increase in the average monthly number of adolescents with a positive result from 1.6 to 2.4 and linkage to TB care services from 2 to 3.1. These were not statistically significant at p=0.170 and p=0.154 respectively.Conclusion The project improved uptake of TB services among adolescents along the TB care cascade (screening, TB testing and linkage to care). We recommend a robust and fully powered randomized controlled trial to evaluate the effectiveness of the package.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNOAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:1-IRB- Mulago Hospital research and ethics committee(MHREC-1922).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableMost of the Data is in the manuscript, however additional information can be provided when requested